shown to be caused by copper deficiency at a critical point in pregnancy and was preventable by copper supplementation to the ewes. 2 In hindsight, the MS cases among swayback researchers were most probably a random coincidence, although it inspired further research.
In 1962, in an Icelandic laboratory, autopsy and biopsy material from two patients with MS was inoculated intracerebrally into sheep. Four of four sheep inoculated from the first patient developed, after on average 18 months, a chronic neurological condition called scrapie, confirmed by histology and passaged to further sheep by intracerebral inoculation. Material from the second patient elicited scrapie only after passages in sheep. 3 Scrapie is a fatal chronic encephalopathy in sheep with ataxia, behavioral changes, itching and rubbing, and biting at sides. It was known in England, Germany, and France since the 18th century. By 1939, it was demonstrated that scrapie is transmissible between sheep, not only by close exposure but also by inoculation with a filterable agent. Corresponding microscopic lesions are vacuoles and inclusion bodies in neurons, without inflammatory infiltrates. 4 Scrapie was later shown to be a prion disorder. 5 The inoculation experiments from patients with MS were repeated, but were unsuccessful in an English laboratory not working with scrapie. Subsequently, MS brain material was inoculated into 18 monkeys who were observed up to 3 years, but no pathology developed. 6 12 After the RNA sequence of a further human lymphotropic retrovirus, the human spumaretrovirus (HSRV), was published in 1991, specific immunoreactivity against this virus was sought for in patients with MS. Again, no reactivity was found in 60 serum/CSF paired samples with a recombinant HSRV envelope antigen. There was no peak in specific immunoreactivity of 7 patients examined with 4-month intervals during 24 months. Adults had higher titers than children, 13 but recent congresses report no human-to-human infection with HSRV.
| SLOW VIRUS DISEASES
Finally, blood and CSF cells from 11 patients with MS were cocultured with allogeneic cells and subjected to gene amplification using PCR for HSRV pol and gag, and HTLV-1 and HTLV-2 pol and env, with plasmid DNA from HSRV as positive control. No evidence was found for spumavirus or oncovirus infection in relapsing-remitting MS. ies were also present in the CSF in 75% of patients with MS and absent in controls. 19 This was confirmed in subsequent studies, but the conclusion was not straightforward. In several chronic infectious and inflammatory diseases, first described in seminal papers by Kabat in 1948-50 for trypanosomiasis and neurosyphilis, soon also for MS, there is a CSF-enriched intrathecal reaction with local immunoglobulin production. This reaction is generally immunospecific in infections of the central nervous system. In SPSS, the bulk of the oligoclonal IgG is absorbable by measles antigen, bearing witness to its specificity.
On the contrary, in MS only a very minor part (approximately 2%) of the intrathecally produced IgG has known specificity, mainly antiviral, while no putative autoantigens have been consistently described for the CSF antibodies. One interpretation has been that the polyclonal intrathecally produced antibodies represent secondary, "nonsense"
reactions. However, the antiviral reaction is restricted to a few viruses, mainly those of childhood diseases with a neurotropic potential. The MRZ (measles-rubella-zoster) antibody reaction with two or three of these antibodies is highly specific for MS. Furthermore, the immunoreactivity against measles was reported to be restricted to two envelope and one nucleocapsid antibody, and similar details of specificity were found for reactivity against rubella virus. These relationships are hardly explained by a random process.
Furthermore, in situ hybridization (ISH) performed at autopsy showed measles RNA in two foci. One of the foci was in a demyelinated area in one of four MS brains, although in the low amount of 1 copy/cell as compared to 10 copies/cell in SSPE. 20 Further ISH studies at the same center showed similar ISH findings in control brains, casting the specificity of the MS findings in doubt. Next, the "age hypothesis" (which may be seen as one aspect of the "hygiene hy- that the age at which several infectious childhood diseases, including measles, occurred was slightly shifted to higher ages for patients with MS. 21 However, in a large material from the Danish MS register and original school health records, no association was found between the age when measles was contracted and the subsequent occurrence of MS. 22 A further argument against a direct involvement of measles in MS pathogenesis was provided by register-based studies on calendar year of MS incidence in birth cohorts related to the implementation of nationwide measles vaccination programs. No prophylactic effect was discerned. 23 Finally, there are at least three reports on the occurrence of measles after MS onset, 24 which is fatal for any contention of obligatory causality.
| HERPESVIRUSES

Herpes simplex virus (HSV) type 1 and 2 infection is characterized by latency with intermittent lytic infection. It is well known that HSV
is transported intra-axonally in peripheral nerves, and its propagation is considered to be restricted to the external branch of the bipolar spinal ganglion. However, experimentally, intra-axonal transport was also demonstrated in the central nervous system.
After injection of the virus into one eye, the virus was recovered from the contralateral corpus geniculatum, probably intra-axonally via the chiasma. Other pathways for HSV propagation in the CNS were also possible. 25 The possible relevance of HSV for MS was tested in therapeutic trials, as discussed elsewhere in this volume.
In the early 1970s, Scandinavian groups found intrathecally produced antibodies against varicella-zoster virus (VZV), in addition to measles, using new methods as imprint immunofixation. 26 The UCLA group extended its PCR findings of viral genomes in the brain to include VZV, found in brains of 43% of patients with MS and 32% of controls. The difference was considered non-significant. 27 An elegant explanation of intermittently PCR-positive findings of VZV in the CSF was provided, as results of destruction of medullary and brain stem sensory neurons. 28 A surprising result concerning cytomegalovirus (CMV) is that seropositivity against CMV was negatively associated with MS, with OR 0.73 (CI 0.58-0.92).
It remains to be determined whether it has a protective effect against MS. 29 Human herpesvirus A and B (HHV6 A and B The frequency may be higher in encephalopathy. 32, 33 However, the presence of HHV DNA in brain was thought to reflect reactiva- (ii) Increased MS risk after infectious mononucleosis was first observed an a case-control study 34 and a cohort study. 35 The EBV paradox of relatively low CSF anti-EBV antibodies contrasting with high serum antibodies is discussed elsewhere in this volume. This finding may fit into the "tertiary lymphatic organ (TLO) hypothesis,"
suggesting that EBV lymphotropic infection starting in the preclinical stages of MS produces TLO in the meninges, sulci, and brain parenchyma, forming niches for plasma cells producing antibodies with specificity for the subsequent, mainly neurotropic, infections of the individual (see MRZ reaction above). 36 As for risk factors in other complex disorders, proof of causality is extremely difficult to obtain, and a more decisive test may require implementation of large-scale prophylaxis, which is contentious. However, vaccination against the EBV glycoprotein 350 was successful in reducing the prevalence of infectious mononucleosis. Table 1 shows examples of results obtained with this technique.
However, a relationship between common infections and inflammatory activity was not convincingly confirmed by three MRI studies based on new lesions. 43 Furthermore, no specific immunoreactivity was reported for putative triggering infections. A large proportion of these common infections are caused by rhinovirus. A rhinovirus-specific PCR study on nasopharyngeal secretion showed several infections but no temporal relationship to MS relapses. 44 We have to consider that in addition to specific immunological triggering, a moderately strong relationship between infections and MS may be unspecific, due to the fact that infection-related "malaise" and post-infectious fatigue are often more pronounced and protracted in MS. Whereas investigators presumably tried to separate pseudorelapses owing to temperaturerelated conduction blocks in demyelinated nerves from genuine MS relapses, the distinction may be difficult, possibly leading to false recording of triggering events.
Major topics not covered in the present introduction are the remote control of brain autoimmunity by the gut microbiome, 45 and the controversial area of endogenous retroviruses. 46 A number of agents belonging to these areas are described elsewhere in this volume.
Recently, awareness of the importance of alveolar T-cell modification 47 has opened a new research area possibly implicating respiratory infections.
| FAMILY STUDIES SET LIMITS FOR AN ENVIRONMENTAL INFECTION FACTOR
The established risk factors, genetic (HLA and non-HLA) and environmental (vitamin D deficiency, smoking, infectious mononucleosis), may influence the average population prevalence of 2 pm to vary between a fraction of 0.5 pm to approximately 10 pm. However, we need to explain the gross level of the prevalence around 2 pm.
George Ebers' studies on adoptees and half-siblings 48 What could we conclude concerning the external factor, knowing it is non-shared and supposing it is an infection? It should be a ubiquitous infection with a very low symptom/infection ratio. That the symptom/infection ratio is in the order of magnitude of a few promille is not unreasonable. Analogies with very low manifest symptom rates T A B L E 1 Risk of MS relapses following infections using AR/NAR statistics. F I G U R E 1 Reproduced with permission from the Lancet. 48 Showing that the recurrence risk for adoptees is markedly lower than for the biological siblings, and similar to the population risk 
Ref. AR/NAR Significance
| CONCLUSION: ABANDONED AND SURVIVING HYPOTHESES
The intention is not to determine which hypotheses are useful or true, rather to provide a rationale for the selection of topics relevant for today's research (and for this volume). According to the reasoning above, it is reasonable to consider the ubiquitous infections to be the most relevant candidates in MS pathogenesis. The herpes group seems to be an outstanding example.
History indicates that abandoned hypotheses would include scrapie, prion diseases, exogenous retroviruses and a group of other "slow viruses," SSPE, and JCV.
Surviving hypotheses would include herpesviruses, notably the ubiquitous HHV6 and EBV, the TLO hypothesis involving the MRZ reaction, and the related hygiene hypothesis. Endogenous retroviruses and remote effects from the gut microbiome are also objects of ongoing research. This volume presents numerous arguments relevant for these apparently surviving hypotheses.
F I G U R E 2
Showing that the risk-adjusted MS prevalence, that is, the prevalence range considering the known epidemiological risk factors, varies between a fraction of a promille and approximately 10 promille. The gross population risk of MS is approximately 2 promille, similar to the symptom/infection ratio for poliomyelitis and other infections
